Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Vaillancourt

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioconjugate Chemistry|June 14, 2024
Squaramide Formation for DNA-Encoded Library SynthesisAntoine Douchez, Julien Poupart, Gaoqiang Yang, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 27, 2017
Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1Louis Vaillancourt, Eleni Papanagnu, Marwan Elfekhfakh, et al.
The British Journal of Ophthalmology|June 3, 2015
The Boston Keratoprosthesis type 1 as primary penetrating corneal procedureRaphaëlle Fadous, Samuel Levallois-Gignac, Louis Vaillancourt, et al.
Organic Letters|June 14, 2018
Pyrimidine as an Aryl C-H Activating GroupSahaj Gupta, Jennifer A Melanson, Louis Vaillancourt, et al.
Cornea|January 7, 2017
Corneal Densitometry as a Tool to Measure Epithelial Ingrowth After Laser In Situ KeratomileusisDaniel Adran, Louis Vaillancourt, Mona Harissi-Dagher, et al.
Journal of Medicinal Chemistry|August 20, 2019
Exposing Small-Molecule Nanoentities by a Nuclear Magnetic Resonance Relaxation AssayYann Ayotte, Victoria M Marando, Louis Vaillancourt, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2005
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positionsWilliam Kemnitzer, Shailaja Kasibhatla, Songchun Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioconjugate Chemistry|June 14, 2024
Squaramide Formation for DNA-Encoded Library SynthesisAntoine Douchez, Julien Poupart, Gaoqiang Yang, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 27, 2017
Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1Louis Vaillancourt, Eleni Papanagnu, Marwan Elfekhfakh, et al.
The British Journal of Ophthalmology|June 3, 2015
The Boston Keratoprosthesis type 1 as primary penetrating corneal procedureRaphaëlle Fadous, Samuel Levallois-Gignac, Louis Vaillancourt, et al.
Organic Letters|June 14, 2018
Pyrimidine as an Aryl C-H Activating GroupSahaj Gupta, Jennifer A Melanson, Louis Vaillancourt, et al.
Cornea|January 7, 2017
Corneal Densitometry as a Tool to Measure Epithelial Ingrowth After Laser In Situ KeratomileusisDaniel Adran, Louis Vaillancourt, Mona Harissi-Dagher, et al.
Journal of Medicinal Chemistry|August 20, 2019
Exposing Small-Molecule Nanoentities by a Nuclear Magnetic Resonance Relaxation AssayYann Ayotte, Victoria M Marando, Louis Vaillancourt, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2005
Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positionsWilliam Kemnitzer, Shailaja Kasibhatla, Songchun Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Pageof 1